SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-073945
Filing Date
2020-06-17
Accepted
2020-06-17 06:02:25
Documents
3
Period of Report
2020-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022699d1_8k.htm 8-K 22735
2 EXHIBIT 10.1 tm2022699d1_ex10-1.htm EX-10.1 46504
3 EXHIBIT 10.2 tm2022699d1_ex10-2.htm EX-10.2 64522
  Complete submission text file 0001104659-20-073945.txt   135225
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 20967999
SIC: 2834 Pharmaceutical Preparations